NAMSA to Acquire WuXi AppTec’s U.S. Medical Device Testing Operations
NAMSA, a global leader in MedTech testing, clinical, and regulatory consulting, has announced a definitive agreement to acquire WuXi AppTec’s U.S. medical device testing operations. The deal includes facilities in Minnesota and Georgia, further strengthening NAMSA’s capabilities in supporting medical device development and regulatory compliance.
NAMSA to Acquire WuXi AppTec’s U.S. Medical Device Testing Operations